Sector revisions Abbott Laboratories

Stocks

Market Closed - NYSE 23:04:05 11/09/2026 +03			5-day change	1st Jan Change
101.95 ^USD	-1.36%		-5.89%	-18.63%

09-08	Abbott Receives FDA Approval for Device to Treat Abnormal Heart Rhythm	DJ
09-08	Abbott Receives FDA Approval for TactiFlex Duo Ablation Catheter to Treat Abnormal Heart Rhythms	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ABBOTT LABORATORIES							25
	MEDTRONIC PLC							25
	CENCORA, INC.							13
	HOYA CORPORATION							15
	BECTON, DICKINSON AND COMPANY							12
	DEXCOM, INC.							25
	MEDLINE INC.							25
	WEST PHARMACEUTICAL SERVICES, INC.							16
	TERUMO CORPORATION							13
	SARTORIUS STEDIM BIOTECH							14
	STERIS PLC							8
	ZIMMER BIOMET HOLDINGS, INC.							21
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	SOLVENTUM CORPORATION							13
	BAXTER INTERNATIONAL INC.							11
	ALIGN TECHNOLOGY, INC.							15
	AVANTOR, INC.							15
	GLOBUS MEDICAL, INC.							13
	BIO-RAD LABORATORIES, INC.							5
	DEMANT A/S							20
	Average							16
	Weighted average by Cap.							19

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!